Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
CSPC Pharmaceutical Group ( (HK:1093) ) has shared an announcement.
CSPC Pharmaceutical Group Limited has announced a board meeting scheduled for May 29, 2025, to approve the unaudited first quarterly results for the period ending March 31, 2025. This meeting is significant as it will provide insights into the company’s financial performance for the first quarter of 2025, which could impact its market positioning and stakeholder confidence.
The most recent analyst rating on (HK:1093) stock is a Buy with a HK$10.26 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating in the pharmaceutical industry. It focuses on the development, manufacture, and sale of pharmaceutical products.
YTD Price Performance: 23.25%
Average Trading Volume: 145,397,173
Technical Sentiment Signal: Buy
Current Market Cap: HK$67.73B
For a thorough assessment of 1093 stock, go to TipRanks’ Stock Analysis page.